telcagepant inn code name calcitonin generelated peptide receptor antagonist investigational drug acute treatment prevention migraine developed merck acute treatment migraine found equal efficacy phase iia clinical trial studying telcagepant prophylaxis episodic migraine stopped march identification two patients significant elevations serum memo study locations stated telcagepant preliminarily reported increase hepatic liver enzyme alanine transaminase alt levels randomized doubleblinded study participants study participants told stop taking july merck announced discontinued development httpsenwikipediaorgwikitelcagepant